Articles From: Plantronics to Spotlight the Power of WebRTC and Wearables at AT&T Developer Summit and Hackathon 2015 to Change in Number of Shares and Votes in Meda


2014/12/30
http://www.marketwire.com/library/MwGo/2014/12/30/11G029327/PLT_logo_blue_1.5inch-15529132287.jpg SANTA CRUZ, CA--(Marketwired - December 30, 2014) - Plantronics (NYSE: PLT), will kick-off 2015 by showcasing WebRTC and wearable tech innovations at the upcoming AT&T Developers Summit and Hackathon in Las Vegas, NV, January 3-5.
Sign-up for Plantronics to Spotlight the Power of WebRTC and Wearables at AT&T Developer Summit and Hackathon 2015 investment picks
2014/12/30
CHONGQING, China , Dec.
Sign-up for Daqo New Energy Corp. Announces Resolution Adopted at 2014 Annual General Meeting investment picks
2014/12/30
OWINGS MILLS, Md.
Sign-up for Medifast, Inc. to Participate in the 17th Annual ICR XChange Conference investment picks
2014/12/30
General Moly, Inc. (the "Company" or “General Moly”) (NYSE MKT and TSX: GMO), a U.S.-based molybdenum mineral development, exploration, and mining company, announced that it has closed the private placement of units announced on December 23, 2014, consisting of senior convertible notes and warrants, ("Private Placement") for gross proceeds of $8.535 million.
Sign-up for General Moly Announces Closing of Private Placement Financing investment picks
2014/12/30
-- On Schedule to Release Topline Data from Phase 1b Clinical Trial and to Start Phase 2 Clinical Trial of SYN-004 in 1Q 2015 --
Sign-up for Synthetic Biologics Announces First Patient Dosed in Phase 1b Clinical Trial of SYN-004 for the Prevention of C. difficile Infection investment picks
2014/12/30
NeuroDerm Ltd.
Sign-up for NeuroDerm shares surge 19.6% as Parkinson's treatment shows promise investment picks
2014/12/30
PHILADELPHIA , Dec.
Sign-up for Echo Therapeutics Appoints Alan W. Schoenbart as Chief Financial Officer investment picks
2014/12/30
ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) and Angelini Pharma, through the Austrian subsidiary CSC Pharmaceuticals, today announced that ARIAD has granted Angelini exclusive rights to commercialize Iclusig ® (ponatinib) for the indications approved by the European Medicine Agency (EMA) in Central and Eastern Europe.
Sign-up for ARIAD Announces Commercialization Agreement for Iclusig in Seven Central and Eastern European Countries investment picks
2014/12/30
PRINCETON, N.J., Dec.
Sign-up for Advaxis's Cancer Immunotherapies Featured on FOX News' Sunday Housecall investment picks
2014/12/30
1985 was a pivotal year for the memory market in the Americas.
Sign-up for Avnet Electronics Marketing Americas Celebrates 30-Year Anniversary with Micron Technology investment picks
2014/12/30
With high-winds on the horizon, customers urged to have a preparedness plan ready and to stay safe SAN FRANCISCO, Calif.
Sign-up for PG&E Implementing Plans For Pending Wind Storm investment picks
2014/12/30
CICERO, Ill., Dec.
Sign-up for Broadwind Energy to Present at Sidoti & Company Emerging Growth Institutional Investor Forum investment picks
2014/12/30
WORCESTER, Mass., Dec.
Sign-up for World Energy Solutions Announces Expiration of the "Go-Shop" Period investment picks
2014/12/30
BRENTWOOD, Tenn.
Sign-up for Brookdale Appoints William G. Petty, Jr. to Board of Directors investment picks
2014/12/30
The estimated global market of Rheumatoid Arthritis is expected to reach $38B in 2017 PETACH TIKVA, Israel , Dec.
Sign-up for Can-Fite Completes the Design of the Rheumatoid Arthritis Phase III Study of Its Lead Drug Candidate CF101 investment picks
2014/12/30
The Mississippi Board of Psychology is pleased to announce two new online payment services now available for licensed psychologists.
Sign-up for Mississippi Board of Psychology Launches Two New Online Services investment picks
2014/12/30
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced today completion of the rolling submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for asfotase alfa, an investigational, first-in-class enzyme replacement therapy for the treatment of hypophosphatasia (HPP). HPP is a genetic, chronic and progressive ultra-rare metabolic disease that can lead to destruction and deformity of bones, profound muscle weakness, seizures, respiratory failure and premature death.
Sign-up for Alexion Completes Rolling BLA Submission to U.S. FDA for Asfotase Alfa as a Treatment for Patients with Hypophosphatasia investment picks
2014/12/30
Focus on enabling computer literacy BANGALORE, India , December 30, 2014 /PRNewswire/ -- Infosys today announced that it would expand its Corporate Social Responsibility (CSR) activities in the Americas through its philanthropic arm, the Infosys Foundation, USA .
Sign-up for Infosys Expands its CSR Activities With Infosys Foundation, USA investment picks
2014/12/30
Nearly half (46 percent) of the recipients of assistance from human services agencies surveyed by Accenture (NYSE:ACN) across the United States say they would likely download and use a mobile application for obtaining services.
Sign-up for Accenture Survey Shows That Mobile Access to Human Services Can Benefit Recipients investment picks
2014/12/30
Solidifies Dedicated, Highly Skilled Management Teams for All Sponsored Programs Executes on Previously Announced Best Practices Governance Initiatives; Enhances 'Investor First' Approach Simplifies Sponsored Programs' Board Structure, Eliminates Overlap and Increases Board Independence NEW YORK , Dec.
Sign-up for AR Capital Announces Board of Director Changes in Its Sponsored Programs investment picks
2014/12/30
Chocolate lovers rejoice! Krispy Kreme has combined the smooth taste of three decadent chocolate flavors into one scrumptious new chocolate treat.
Sign-up for Decadent and Delicious: Krispy Kreme Introduces New Triple Chocolate Treat investment picks
2014/12/30
NANJING , China , Dec.
Sign-up for China Sunergy Announces Shareholder Resolutions Adopted at 2014 Annual General Meeting investment picks
2014/12/30
HSINCHU, Dec.
Sign-up for MERGER UPDATE: ChipMOS' SUBSIDIARIES APPROVE MERGER AGREEMENT investment picks
2014/12/30
HANGZHOU, China, Dec.
Sign-up for Sky-mobi Limited Announces Results of 2014 Annual General Meeting investment picks
2014/12/30
BEIJING , Dec.
Sign-up for China Digital TV Appoints Yue Qian as New Acting CFO investment picks
2014/12/30
HAMILTON, Bermuda, Dec.
Sign-up for SFL - Sale of the ultra-deepwater drillship "West Polaris" investment picks
2014/12/30
SHENZHEN, China , Dec.
Sign-up for China Nepstar Chain Drugstore Announces $5 Million Share Repurchase Program investment picks
2014/12/30
Partner Communications Company Ltd.
Sign-up for Partner Communications Announces the Resignation of Mr. Yahel Shachar from the Board of Directors investment picks
2014/12/30
Regulatory News: The rights issue recently conducted by Meda AB (STO:MEDA-A) (Pink Sheets:MDABY) has resulted in an increase of shares and votes during December 2014 of in total 33,224,306 shares of series A and the equivalent number of votes.
Sign-up for Change in Number of Shares and Votes in Meda investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Plantronics to Spotlight the Power of WebRTC and Wearables at AT&T Developer Summit and Hackathon 2015 to Change in Number of Shares and Votes in Meda
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent